Identification | Back Directory | [Name]
apogossypol | [CAS]
66389-74-0 | [Synonyms]
NSC736630 apogossypol (+)-APOGOSSYPOL APOGOSSYPOL;NSC736630 (+)-3,3'-Dimethyl-5,5'-bis(1-methylethyl)-2,2'-binaphthalene-1,1',6,6',7,7'-hexol [2,2'-Binaphthalene]-1,1',6,6',7,7'-hexol, 3,3'-dimethyl-5,5'-bis(1-methylethyl)-, (2S)- 3-methyl-5-propan-2-yl-2-(1,6,7-trihydroxy-3-methyl-5-propan-2-ylnaphthalen-2-yl)naphthalene-1,6,7-triol | [Molecular Formula]
C28H30O6 | [MOL File]
66389-74-0.mol | [Molecular Weight]
462.53 |
Chemical Properties | Back Directory | [Melting point ]
118-123 °C | [Boiling point ]
673.3±50.0 °C(Predicted) | [density ]
1.335±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
>16.2mg/mL in DMSO with gentle warming | [form ]
Powder | [pka]
8.03±0.50(Predicted) |
Hazard Information | Back Directory | [Biological Activity]
(+)-Apogossypol is a pan-BCL-2 antagonist that binds to Mcl-1, Bcl-2 and Bcl-xL with EC50 of 2.6, 2.8 and 3.69 μM, respectively. | [in vitro]
In agreement with NMR binding and fluorescence polarization assays (FPAs) data, (+)-Apogossypol displays potent binding affinity to Bcl-xL with K d values of 1.7 μM. | [in vivo]
Due to its modified structure, (+)-Apogossypol is expected to exhibit lower toxicity while maintaining the significant anti-growth and anti-tumor activities in vitro, similar to those of Gossypol. | [target]
Mcl-1 < span> 2.6 μM (EC 50 ) | Bcl-2 2.8 μM (EC 50 ) | Bcl-xL 3.69 μM (EC 50 ) | | [storage]
Store at -20°C |
|
Company Name: |
Musechem
|
Tel: |
+1-800-259-7612 |
Website: |
www.musechem.com |
Company Name: |
BOC Sciences
|
Tel: |
16314854226 |
Website: |
www.bocsci.com |
Company Name: |
MedChemExpress
|
Tel: |
021-58955995 |
Website: |
www.medchemexpress.com |
|